Research continues to end COVID-19, which has been affecting our lives for about a year and a half and has claimed 4.55 million lives to date. After billions of doses of vaccine were distributed all over the world, scientists started working on COVID-19 drugs, which they said would provide high protection against the virus when combined with the vaccine.
Remdesivir was one of the most talked about drugs both in our country and all over the world. Remdesivir, which is the only drug approved for use in the treatment of COVID-19 by the American Food and Drug Administration (FDA), provides great protection against COVID-19, according to research by the American-based biopharmaceutical company.
Remdesivir significantly reduces the rate of intensive care admissions
President of the US National Institute of Allergy and Infectious Diseases, Dr. Anthony Fauci previously commented on Remdesivir and stated that the drug has a clear cure in the treatment of COVID-19; “The data show that Remdesiviri has a clear, significant and positive effect on recovery time.”
Fauci’s words were proven months later, and Gilead Sciences Inc announced that Remdesivir was effective against COVID-19 on both early and advanced patients. According to the statements made, Remdesivir reduces the rate of intensive care hospitalization due to COVID-19 by 87%. The drug works well in patients with severe infections, but is also effective in patients in whom the infection has not yet spread much in the early period.
31827
